Seroprevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea, in 2015
- PMID: 31720054
- PMCID: PMC6831962
- DOI: 10.5365/wpsar.2018.9.3.002
Seroprevalence of Middle East respiratory syndrome coronavirus (MERS-CoV) in public health workers responding to a MERS outbreak in Seoul, Republic of Korea, in 2015
References
-
- Interim US guidance for monitoring and movement of persons with potential Middle East respiratory syndrome coronavirus (MERS-CoV) exposure. Atlanta, GA: Centers for Disease Control and Prevention; 8 April 2018 (https://www.cdc.gov/coronavirus/mers/hcp/monitoring-movement-guidance.html)
-
- Cohen BJ, Audet S, Andrews N, Beeler J. WHO working group on measles plaque reduction neutralization test. Plaque reduction neutralization test for measles antibodies: Description of a standardised laboratory method for use in immunogenicity studies of aerosol vaccination. Vaccine. 2007. December 21;26(1):59–66. 10.1016/j.vaccine.2007.10.046 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources